Q3 2012
Released Nov 9, 2012, during market hours
10-Q filed Nov 9, 2012, 40 days after period end · 0001144204-12-060660
Q3 2012 · 10-Q
Revenue$604.00K$604.00K +48.4% vs Q3 2011+100.0% vs Q2 2012
Net Income-$853.00K-$853.00K N/M vs Q3 2011N/M vs Q2 2012
EPS Diluted-$0.07-$0.07 N/M vs Q3 2011N/M vs Q2 2012
Gross Profit$413,000+33.7%
Operating Income-$853,000N/M
Operating Cash Flowderived-$717,000N/M
Free Cash Flowderived-$717,000—
Margins · derived
Gross margin68.4%−7.5 pt vs Q3 2011
Operating margin-141.2%−36.8 pt vs Q3 2011
Net margin-141.2%−39.8 pt vs Q3 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $604.00K | $407.00K | $622.00K |
| Net Income | -$853.00K | -$413.00K | -$375.00K |
| EPS Diluted | -$0.07 | -$0.04 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR